期刊文献+

低浓度雷公藤甲素联合伊达比星诱导急性髓系白血病干细胞凋亡及其机制 被引量:5

Low-dose Triptolide in Combination with Idarubicin Induce Apoptosis of Acute Myeloid Leukemia Stem Cells Via Modulation of HIF-1α Pathways
下载PDF
导出
摘要 【目的】探讨低浓度雷公藤甲素联合伊达比星(IDA)在体外对急性髓系白血病细胞(AML)干细胞凋亡的影响及其分子机制。【方法】应用流式细胞仪分选KG1a细胞中具有AML干细胞特性的CD34+CD38-亚群;对分选的CD34+CD38-KG-1α细胞进行免疫表型和细胞周期的测定;流式细胞术检测IC20浓度的雷公藤甲素、IC50浓度的IDA单药及上述浓度的雷公藤甲素联合IDA对CD34+CD38-KG1a细胞的诱导凋亡作用;蛋白质印迹法检测药物处理后HIF-1a及其下游CXCR4、VLA-4蛋白表达水平的变化。【结果】分选后CD34+CD38-亚群细胞占KG-lα细胞比例达(98.15±1.64)%,,细胞周期检测显示G0/G1期细胞比例达(82.40±3.82)%。空白对照组、IC20浓度的雷公藤甲素(5 nmol/L)单药组、IC50浓度的IDA(27nmol/L)单药组及上述浓度的雷公藤甲素联合IDA组作用于AML干细胞细胞,24 h凋亡率分别为:(5.63±0.67)%、(9.11±0.33)%、(24.85±1.70)%和(76.87±8.34)%,联合组诱导AML干细胞凋亡比较显著高于雷公藤甲素单药组及IDA单药组(均P<0.001)。蛋白质印迹法结果显示单药组及联合组均可以不同程度下调AML干细胞HIF-1a、CXCR4及VLA-4蛋白的表达水平,其中联合组最为明显。【结论】低浓度雷公藤甲素可显著提高IDA对AML干细胞诱导凋亡作用,其机制可能是通过抑制HIF-1α及其下游通路实现的。 [Objective] To investigate the effect of low-dose triptolide (TRI) in combination with idarubicin (IDA) on acute myeloid leukemia stem cells and the relationship with HIF-1α pathway.[Methods] CD34^+CD38^-KG1a cells was sorted from KG1a cell lines by fluorence-activated cell sorting (FACS) analysis.Immunophenotype and cell cycle analysis of CD34^+CD38^-KG1a cells were analyzed by fluorescence-activated cell sorting analysis.Annexin-V/PI double staining was used to detect the effects of low-dose TRI in combination with IDA on apoptosis of CD34^+CD38^-KG1a cells.Western bloting to analyze the expression of HIF-1α and its downstream protein CXCR4,VLA-4 in CD34^+CD38^-KG1a cells after treatment with TRI,IDA,and TRI+IDA.[Results] After sorting,98.15-± 1.64% of the cells were labeled for CD34^+CD38^-.Cell cycle analysis also showed that proportion of G0/G1 cells was 82.4 ± 3.82%.CD34^+CD38^-KG1a cells were exposed to 5 nmol/L TPL,27 nmol/L IDA and TRI±IDA for 24 h.The apoptotic cells were determined by PI/Annexin V staining and flow cytometric analysis.Apoptotic ratio of cells treated by IDA with TPL was significantly increased compared to cells treated by IDA alone (24.85 ± 1.70% vs.76.87 ± 8.34%,P 〈 0.001).Western blot results showed markedly decrease the expression of HIF-1α,CXCR4 and VLA-4 in CD34^+CD38^-KG1a cells treated with low-dose TRI in combination with IDA.[Conclusion] A relatively low concentration of TPL in combination with IDA could induce apoptosis of AML stem cells in vitro via inhibition of HIF-1α pathway.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2014年第5期667-671,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 国家自然科学基金(81070425) 广东省科技计划项目(2011B031800063)
关键词 AML干细胞 雷公藤甲素 IDA HIF-1A triptolide (TRI) idarubicin (IDA) acute myeloid leukemia stem cells HIF-1α pathway
  • 相关文献

参考文献2

二级参考文献56

  • 1Chen BJ. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma 2001; 42: 253-65.
  • 2Tao XL, Sun Y, Dong Y, Xiao YL, Hu DW, Shi YP, et al. A prospective, controlled, double-blind, cross-over study of Tripterygium wilfodii hook F in treatment of rheumatoid arthritis. Chin Med J (Engl) 1989; 102: 327-32.
  • 3Shamon LA, Pezzuto JM, Graves JM, Mehta RR, Wangcharoentrakul S, Sangsuwan R, et al. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett1997; 112: 113-7.
  • 4Carter BZ, Mak DH, Schober WD, McQueen T, Harris D, Estrov Z, et al. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells. Blood 2006; 108: 630-7.
  • 5Lou Y J, Jin J. Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leuk Lymphoma 2004; 45: 373-6.
  • 6Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, et al. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T3151 mutation. Clin Cancer Res 2009; 15: 1686-97.
  • 7Yinjun L, Jie J, Yungui W. Triptolide inhibits transcription factor NF- kappaB and induces apoptosis of multiple myeloma cells. Leuk Res 2005; 29: 99-105.
  • 8Lu LH, Lian YY, He GY, Lin SP, Huan SH, Chen ZZ, et al. Clinical study of triptolide in treatment of acute leukemia. Clin Exp Investig Hematol 1992; 3: 1-3.
  • 9Kiviharju TM, Lecane PS, Sellers RG, Peehl DM. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 2002; 8: 2666-74.
  • 10Harousseau JL, Dombret H, Pigneux A, Michailet M, Brandely M. Phase I study of F60008, a triptolide derivative, in patients with refractory or relapsing acute leukemias. Haematologica 2008; 93(s1): 14 abs. 0038.

共引文献13

同被引文献62

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部